Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14862-52-3

Post Buying Request

14862-52-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14862-52-3 Usage

Description

1,3-Dibromo-5-chlorobenzene is an organic compound that exists as a white to light yellow crystal powder. It is characterized by its chemical structure, which includes two bromine atoms at the 1st and 3rd positions, and a chlorine atom at the 5th position on a benzene ring.

Uses

1. Used in Pharmaceutical Industry:
1,3-Dibromo-5-chlorobenzene is used as a reactant for the preparation of orally bioavailable 1-(1H-indol-4-yl)-3,5-disubstituted benzene analogs. These analogs serve as antimitotic agents, which are crucial in the development of medications targeting cell division and potentially useful in cancer treatment.
2. Used in Chemical Synthesis:
1,3-Dibromo-5-chlorobenzene can be utilized as an intermediate in the synthesis of various organic compounds due to its unique halogenated structure. This makes it a valuable component in the production of dyes, pesticides, and other specialty chemicals.
3. Used in Research and Development:
In the field of scientific research, 1,3-Dibromo-5-chlorobenzene may be employed as a starting material or a reagent in the development of new chemical compounds with potential applications in various industries, including pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 14862-52-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,8,6 and 2 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 14862-52:
(7*1)+(6*4)+(5*8)+(4*6)+(3*2)+(2*5)+(1*2)=113
113 % 10 = 3
So 14862-52-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Br2Cl/c7-4-1-5(8)3-6(9)2-4/h1-3H

14862-52-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (B25411)  1,3-Dibromo-5-chlorobenzene, 98%   

  • 14862-52-3

  • 1g

  • 247.0CNY

  • Detail
  • Alfa Aesar

  • (B25411)  1,3-Dibromo-5-chlorobenzene, 98%   

  • 14862-52-3

  • 5g

  • 738.0CNY

  • Detail
  • Alfa Aesar

  • (B25411)  1,3-Dibromo-5-chlorobenzene, 98%   

  • 14862-52-3

  • 25g

  • 2279.0CNY

  • Detail

14862-52-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3-Dibromo-5-chlorobenzene

1.2 Other means of identification

Product number -
Other names 1,3-DibroMo-5-chlorobenzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14862-52-3 SDS

14862-52-3Relevant articles and documents

The acidifying effects of chlorine and bromine: Little difference

Mongin, Florence,Schlosser, Manfred

, p. 1559 - 1562 (1997)

Lithium diisopropylamide deprotonates ortho- and para-bromochlorobenzene randomly at the two halogen adjacent positions. Obviously for steric reasons, the bulkier base lithium 2,2,6,6-tetramethylpiperidide favors the attack in the vicinity of the chlorine rather than the bromine atom to the extent of 2:1. At -75°C, both 2-bromo-3-chlorophenyllithium and 3-bromo-2-chlorophenyllithium isomerize to give 2-bromo-6-chlorophenyllithium. The latter species can be directly generated from 1-bromo-3-chlorobenzene.

Structure-activity relationship studies of novel benzophenones leading to the discovery of a potent, next generation HIV nonnucleoside reverse transcriptase inhibitor

Romines, Karen R.,Freeman, George A.,Schaller, Lee T.,Cowan, Jill R.,Gonzales, Steve S.,Tidwell, Jeffrey H.,Andrews III, Clarence W.,Stammers, David K.,Hazen, Richard J.,Ferris, Robert G.,Short, Steven A.,Chan, Joseph H.,Boone, Lawrence R.

, p. 727 - 739 (2007/10/03)

Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human immunodeficiency virus (HIV). This is particularly true for the growing number of patients infected with virus resistant to currently approved HIV drugs. Our high throughput screening effort identified a benzophenone template as a potential nonnucleoside reverse transcriptase inhibitor (NNRTI). This manuscript describes our extensive exploration of the benzophenone structure-activity relationships, which culminated in the identification of several compounds with very potent inhibition of both wild type and clinically relevant NNRTI-resistant mutant strains of HIV. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC50 values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14862-52-3